Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 12 a 31 di 35
Titolo Data di pubblicazione Autore(i) File
Feedback inhibition by RALT controls signal output by the ErbB network 2003 Anastasi, S.; Fiorentino, L.; Fiorini, M.; Fraioli, R.; Sala, G.; Castellani, L.; Alema, S.; Alimandi, M.; Segatto, O.
FLASH degradation in response to UV-C results in histone locus bodies disruption and cell-cycle arrest 2010 Bongiorno Borbone, Lucilla; De Cola, Antonella; Barcaroli, Daniela; Knight Richard, A; DI ILIO, Carmine; Melino, Gerry; DE LAURENZI, Vincenzo
FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription. 2012 A., De Cola; L., Bongiorno Borbone; E., Bianchi; D., Barcaroli; Carletti, Erminia; R. A., Knight; DI ILIO, Carmine; G., Melino; C., Sette; DE LAURENZI, Vincenzo
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 2018 Ferro, R.; Adamska, A.; Lattanzio, R.; Mavrommati, I.; Edling, C. E.; Arifin, S. A.; Fyffe, C. A.; Sala, G.; Sacchetto, L.; Chiorino, G.; De Laurenzi, V.; Piantelli, M.; Sansom, O. J.; Maffucci, T.; Falasca, M.
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. 2005 Di Stefano, V; Soddu, S; Sacchi, A; D'Orazi, Gabriella
HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function 2004 Di Stefano, V; Blandino, G; Sacchi, A; Soddu, S; D'Orazi, Gabriella
Immune responses to all ErbB family receptors detectable in serum of cancer patients 1999 Bei, R; Masuelli, L; Moriconi, E; Visco, V; Moretti, A; Kraus, M. H.; Muraro, Raffaella
Inositol pentakisphosphate promotes apoptotis through the PI 3- K/Akt pathway 2004 Piccolo, E; Vignati, S; Maffucci, T; Innominato, Pf; Riley, Am; Potter, Bv; Pandolfi, Pp; Broggini, M; Iacobelli, Stefano; Innocenti, Paolo; Falasca, M.
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin 2005 Anastasi, S.; Sala, G.; Huiping, C.; Caprini, E.; Russo, G.; Iacovelli, S.; Lucini, F.; Ingvarsson, S.; Segatto, O.
MiR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 2012 Acunzo, M.; Visone, Rosa; Romano, G.; Veronese, A.; Lovat, F.; Palmieri, D.; Bottoni, A.; Croce, C. M.
Mutations at coding mononucleotide repeats in gastric cancer with the microsatellite mutator phenotype 1998 Ottini, L; Falchetti, M; D'Amico, C; Amorosi, A; Saieva, C; Masala, G; Frati, L; Cama, Alessandro; Palli, D; MARIANI COSTANTINI, Renato
Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene 2003 Nasr, Ashraf F; Nutini, Michele; Palombo, Barbara; Guerra, Emanuela; Alberti, Savenio
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas 2002 Monica, Fedele; Sabrina, Battista; Lawrence, Kenyon; Gustavo, Baldassarre; Vincenzo, Fidanza; Andres J. P., Klein Szanto; A. F., Parlow; Visone, Rosa; Giovanna M., Pierantoni; Eric, Outwater; Massimo, Santoro; Carlo M., Croce; Alfredo, Fusco
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. 1996 Marchetti, Antonio; Doglioni, C; Barbareschi, M; Buttitta, Fiamma; Pellegrini, S; Bertacca, G; Chella, A; Merlo, G; Angeletti, Ca; Dalla Palma, P; Bevilacqua, G.
PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites. 2001 Santilli, G; Cervellera, Mn; Johnson, Tk; Lewis, Re; Iacobelli, Stefano; Sala, A.
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer 2017 Castagnoli, L.; Ghedini, G. C.; Koschorke, A.; Triulzi, T.; Dugo, M.; Gasparini, P.; Casalini, P.; Palladini, A.; Iezzi, Manuela; Lamolinara, A.; Lollini, P. L.; Nanni, P.; Chiodoni, C.; Tagliabue, E.; Pupa, S. M.
Regulation of microRNA expression by HMGA1 proteins 2009 Ivana De, Martino; Visone, Rosa; Monica, Fedele; Fabio, Petrocca; Dario, Palmieri; Jm, Hoyos; F., Forzati; Carlo Maria, Croce; Alfredo, Fusco
Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. 2010 Puca, R; Nardinocchi, L; Givol, D; D'Orazi, Gabriella
The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. 2002 Piccolo, Enza; Innominato, P. F.; Mariggio', Maria Addolorata; Maffucci, T.; Iacobelli, Stefano; Falasca, Marco
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas 2006 Vitagliano, D.; Portella, G.; Troncone, G.; Francione, A.; Rossi, C.; Bruno, Annalisa; Giorgini, A.; Coluzzi, S.; Nappi, T. C.; Rothstein, J. L.; Pasquinelli, R.; Chiappetta, G.; Terracciano, D.; Macchia, V.; Melillo, Rm; Fusco, A.; Santoro, M.
Mostrati risultati da 12 a 31 di 35
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile